AzTrials
AzTrials

Overweight and ObesityNCT03805295

Implementation and Evaluation of a Before School Physical Activity Program in Revere, MA

A study testing BOKS Program in people with Overweight and Obesity and Physical Activity, run by Massachusetts General Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the implementation of the BOKS program in three schools (K-8) in Revere, MA, and its effect on participating students with regard to BMI, cognitive, and quality of life outcomes. Read more about this study

Who is it for?
Ages 5 to 14 yearsHealthy volunteers can take part
What is being tested?
BOKS Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
188 participants
Where
1 siteUnited States
Study dates
16 Feb 2018to 30 Dec 2018
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 14 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Enrolled in the BOKS program
  • Participating school
  • Age 5-14

Who cannot join

  • No valid consent
  • Not enrolled in BOKS

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Massachusetts General Hospital

    Boston, Massachusetts, 02114

Other trials in United States

About this study

This study evaluates the implementation of the BOKS program in three schools (K-8) in Revere, MA, and its effect on participating students with regard to BMI, cognitive, and quality of life outcomes. BOKS (Build Our Kids' Success) is a before-school physical activity program that has been implemented in over 2,000 elementary and middle schools. Two sessions will be held (Spring 2018 and Winter 2018. This is a cohort study evaluating the impact of program participation on child BMI, quality of life, and executive function.

Being tested
BOKS Program
Medical subject headings
Overweight, Obesity, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BOKS ProgramOther

    12-week physical activity program, occurring 3x/week, lasting 30-60 minutes per session.

Study groups in NCT03805295
Study groupRoleWhat they receive
Spring 2018 ParticipationExperimentalStudents in this arm (40 per school, up to 120 total) will participate in the BOKS program in Winter-Spring 2018. They will serve as the control group in Fall 2018.
Receives: Other: BOKS Program
Fall 2018 ParticipationExperimentalStudents in this arm (40 per school, up to 120 total) will participate in the BOKS program in Fall 2018.
Receives: Other: BOKS Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Body Mass Index (kg/m^2)

    calculated from height and weight

    Measured: Baseline, Follow-up for each session (12 weeks)

Secondary outcomes (2)
  1. Change in Executive Function

    Executive function and attention/concentration as measured by the Flanker Task

    Measured: Baseline, Follow-up for each session (12 weeks)

  2. Change in Quality of Life PedsQL

    Measured by PedsQL, a validated measure of pediatric self-rated quality of life with higher score indicating higher quality of life.

    Measured: Baseline, Follow-up for each session (12 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Jan 2019
  2. Study start16 Feb 2018
  3. Primary completion30 Dec 2018
  4. Study completion30 Dec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Sequential
Masking
None (open label)
Enrolment
188 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03805295
Sponsor's protocol ID
2017P002770
Status last verified
Dec 2025
First submitted
11 Jan 2019
Last updated
23 Dec 2025
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing BOKS Program in people with Overweight and Obesity and Physical Activity, run by Massachusetts General Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 23 Dec 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Body Mass Index (kg/m^2) (time frame: Baseline, Follow-up for each session (12 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in